Fortell AI Hearing Aids vs Otofonix Groove

The Fortell AI Hearing Aids are a premium prescription behind-the-ear device priced at $6,800, earning an A grade with a SoundScore of 6.0/5 in HearAdvisor lab testing—an exceptional result that places this device at the top of the prescription hearing aid category. Speech performance is where the Fortell AI truly distinguishes itself. Speech in noise scores an outstanding 6.0/5, a full 3.89 points above the category average of 2.11/5—the kind of margin that represents a meaningful difference in challenging listening environments like restaurants or group conversations. Speech in quiet also excels at 4.6/5, sitting 1.20 points above the category average. Music streaming performs strongly at 4.2/5, coming in 1.44 points above average for the category. The device does have a notable limitation: own-voice comfort scores just 1.5/5, falling 1.20 points below the category average. This low absolute score suggests wearers may notice occlusion effects when speaking. Feedback handling is excellent at 4.8/5, essentially matching the category average. Best suited for: Users who prioritize understanding speech in difficult listening situations and value streaming quality, and who can tolerate potential own-voice occlusion. Given the premium price point, buyers should weigh whether the exceptional speech-in-noise performance justifies the investment compared to alternatives like the Oticon Intent or Oticon Zeal, which offer strong performance at lower price points.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.